Hope in Every Breakthrough, But at What Emotional Cost?
By- Priyanka Rao & Aswathy Gopi
Department of Psychology, SRM University-AP
The Psychology Behind New Cancer Drug Approvals and Rising Patient Expectations
The U.S. Food and Drug Administration (FDA) recently approved Revtorpyk (gedatolisib), a new cancer drug as a major medical advancement. The media highlights this news with terms such as “breakthrough,”“life-saving,” and “revolutionary,” reflecting optimism about progress in cancer care. For millions of cancer patients and their families these improved treatment approaches provide a sense of hope during a challenging period. However, psychologists and psycho-oncologists emphasize that media reports may sometimes create unrealistic expectations about scientific discoveries. When these do not meet the expectations, patients and their families may experience disappointment and significant emotional distress.
On 14th of July 2026, the FDA approved Revtorpyk (gedatolisib), a targeted therapyfor adults with advanced Hormone Receptor-Positive, HER2-Negative locally advanced or metastatic breast cancer. Clinical trials found that the drug delayed the progression of cancer in eligible patients, making its potential as an important advance in precision oncology. In addition, pharmaceutical companies are also working on newer cancer therapies, including antibody-drug conjugates (ADCs) and bispecific antibodies. These therapies are designed to improve accuracy of cancer treatment while reducing the damage to healthy tissue. Many experts view these therapies as the future of oncology.
The Psychology of Hope
For patients diagnosed with cancer, new treatment developments provide hope for better outcomes, fewer symptoms, and a longer life. According to Snyder’s Hope Theory, hope contains two psychological components: 1) Agency: it is the belief that one can achieve desired goals. 2) Pathways: it is the belief that there are ways to achieve those goals. The availability of the newly approved treatment can strengthen a patient’s hope and confidence. As a result, they may begin to believe that:
“This treatment may work for me”
“I have a new treatment option”
“I still have a chance to overcome cancer”
Research has consistently shown that hope is linked to several positive outcomes including better treatment adherence, reduced anxiety, greater resilience, improved quality of life, and healthier psychological adjustments. Therefore, psycho-oncologists encourage patients to maintain realistic hope while avoiding false reassurance.
When Hope Becomes Unrealistic
Challenges arise when the media exaggerates the benefits of new cancer drug. Although some drugs show promising results, they are effective only for specific types of cancer or genetic profiles. It may help in delaying the progression of the disease rather than provide a cure. Therefore, referring to a treatment as “cancer cure” can create unrealistic expectations. This further leads to anger, hopelessness, loss of trust in healthcare professionals, and disappointment in caregivers and individuals with cancer. This emotional crash is sometimes described as the “hope-disappointment cycle”, where repeated optimism followed by setbacks can continue to depression and emotional exhaustion.
Hope extends beyond the cancer patients to their family caregivers. Caregivers often become emotionally involved in every stage of treatment from diagnosis. They often look for information about new treatments and view each new drug as a source of hope. When outcomes are disappointing, caregivers may experience caregiver burden, chronic stress, decision fatigue, compassion fatigue, and anticipatory grief. Due to this reason, psycho-oncology recognizes that supporting caregivers is as important as cancer patients.
Advancing Cancer through Psychological Support
As cancer research continues to advance, immunotherapies, new targeted therapies, and specific drugs are improving treatment outcomes for many patients. While these developments can lead to unrealistic expectations causing emotional challenges to cancer patients and their caregivers. Psycho-oncologists play an important role in helping cope with the emotional impact of these advances. They help individuals cope with uncertainty, manage fear of recurrence or disease progression, develop realistic treatment expectations, and make informed decisions. As cancer treatment continues to improve, psychological care remains an essential part in helping patients and families. In cancer care, hope is medicine, but like every medicine, it is most effective when given in the right dosage.
